Exercise in Genetic Cardiovascular Conditions
遗传性心血管疾病的锻炼
基本信息
- 批准号:9000740
- 负责人:
- 金额:$ 122.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AmericanArrhythmiaBenefits and RisksCardiacCardiovascular systemCessation of lifeClinicalCohort StudiesConsensusCoronary ArteriosclerosisDataData ReportingDecision MakingEmotionalEnrollmentEuropeExerciseFutureGeneticHealthHeart ArrestHypertrophic CardiomyopathyImplantable DefibrillatorsIndividualLifeLong QT SyndromeLongevityMedicalMethodologyModerate ExerciseMulticenter StudiesOutcomeOutcome StudyPatient CarePatient advocacyPatientsPhysiciansPopulationQuality of lifeRecommendationRecruitment ActivityRegistriesReportingResearch InfrastructureRiskRisk MarkerSafetySeriesSerious Adverse EventSiteSportsStrenuous ExerciseSyncopeVentricular Arrhythmiaadvocacy organizationscohorthigh riskprospectivepsychologicsedentarysudden cardiac death
项目摘要
DESCRIPTION (provided by applicant): Exercise is an integral part of life for millions of Americans. The benefits of exercise are well- known-improvement in longevity and quality of life (QOL). However, while data on safety of exercise for patients with genetic cardiovascular conditions, such as the long QT syndrome (LQTS), and hypertrophic cardiomyopathy (HCM,) are sparse, the risk of sudden cardiac death due to vigorous competitive or recreational activities for these patients is thought to be prohibitively high and these patients are restricted
from participation in not just competitive, but most recreational sports as well, by current consensus statements in both the US and Europe. However, preliminary data suggest that first, many patients with these conditions are exercising despite the restrictions and second, that the risks may be lower than postulated, and that there may be detrimental effects of exercise restriction in these patients. Whether the risks of exercise outweigh the medical and quality-of-life benefits for patients with these LQTS and HCM has never been evaluated prospectively. This study will prospectively investigate the risks and benefits of exercise for patients with LQTS
and HCM in parallel observational cohorts. The study will evaluate the hypothesis that risks of death, cardiac arrest, syncope, or appropriate ICD therapy will not be higher in those exercising moderately or vigorously than the sedentary, and that quality of life will be greater in those exercising. Individuals with HCM and LQT who have chosen to continue to exercise will be identified and enrolled both through traditional recruiting sites, and through partnering with patient-advocacy organizations and less active patients will be enrolled as a comparator group. These subjects will then be followed prospectively for three years. Results of this study will have
an immediate and direct impact on patient care. If the hypotheses are correct, many more individuals will enjoy the benefits of exercise. If the hypotheses prove incorrect, those currently
exercising need to know, and exploratory aims will investigate what phenotypic, clinical, genotypic, and sports-related factors may moderate the impact of exercise on arrhythmic outcomes, and will identify clinical and psychological variables which may moderate the impact of exercise restriction on quality of life.
描述(由申请人提供):运动是数百万美国人生活中不可或缺的一部分。运动的好处是众所周知的--延长寿命和提高生活质量。然而,虽然有关患有遗传性心血管疾病(例如长QT综合征(LQTS)和肥厚性心肌病(HCM))的患者运动安全性的数据很少,但由于这些患者剧烈的竞争或娱乐活动而导致心脏性猝死的风险被认为是过高的,并且这些患者受到限制
从参与不仅是竞争性的,但大多数娱乐体育以及,目前在美国和欧洲的共识声明。然而,初步数据表明,第一,许多患有这些疾病的患者尽管受到限制,但仍在锻炼,第二,风险可能低于假设,并且这些患者的运动限制可能会产生不利影响。对于这些LQTS和HCM患者,运动的风险是否超过医疗和生活质量益处从未进行过前瞻性评估。这项研究将前瞻性地调查运动对LQTS患者的风险和益处
和HCM的平行观察队列。该研究将评估以下假设:中度或剧烈运动的患者死亡、心脏骤停、晕厥或适当ICD治疗的风险不会高于久坐不动的患者,并且运动患者的生活质量会更高。选择继续锻炼的HCM和LQT患者将通过传统招募网站和与患者倡导组织合作进行识别和招募,活动较少的患者将被招募为对照组。这些受试者将接受为期三年的前瞻性随访。这项研究的结果将有
对病人的护理产生直接的影响。如果假设是正确的,更多的人将享受锻炼的好处。如果这些假设被证明是错误的,
运动需要知道,探索性的目的将调查哪些表型,临床,基因型和运动相关因素可能会缓和运动对运动结果的影响,并将确定可能缓和运动限制对生活质量影响的临床和心理变量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL JOHN ACKERMAN其他文献
MICHAEL JOHN ACKERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL JOHN ACKERMAN', 18)}}的其他基金
Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)
婴儿猝死综合症 (SIDS) 中的心脏通道突变
- 批准号:
7492188 - 财政年份:2002
- 资助金额:
$ 122.77万 - 项目类别:
Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)
婴儿猝死综合症 (SIDS) 中的心脏通道突变
- 批准号:
7317600 - 财政年份:2002
- 资助金额:
$ 122.77万 - 项目类别:
Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)
婴儿猝死综合症 (SIDS) 中的心脏通道突变
- 批准号:
8132970 - 财政年份:2002
- 资助金额:
$ 122.77万 - 项目类别:
Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)
婴儿猝死综合症 (SIDS) 中的心脏通道突变
- 批准号:
7676123 - 财政年份:2002
- 资助金额:
$ 122.77万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 122.77万 - 项目类别: